Victory Capital Management
CDLX icon

Victory Capital Management’s Cardlytics CDLX Stock Holding History

Victory Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-455
Closed -$301K – 2735
2021
Q4 		$301K Sell
455
-11
-2% -$8.41K ﹤0.01% 2380
2021
Q3 		$391K Sell
466
-251
-35% -$255K ﹤0.01% 2292
2021
Q2 		$910K Sell
717
-309
-30% -$349K ﹤0.01% 1928
2021
Q1 		$1.13M Sell
1,026
-45
-4% -$59.4K ﹤0.01% 1863
2020
Q4 		$1.53M Sell
1,071
-97
-8% -$103K ﹤0.01% 1606
2020
Q3 		$824K Sell
1,168
-30,447
-96% -$22.1M ﹤0.01% 1791
2020
Q2 		$22.1M Sell
31,615
-26,700
-46% -$15.4M 0.03% 730
2020
Q1 		$20.4M Buy
58,315
+26,632
+84% +$18.9M 0.02% 880
2019
Q4 		$19.9M Buy
31,683
+31,492
+16,488% +$15.4M 0.02% 824
2019
Q3 		$64K Buy
+191
New +$61.2K ﹤0.01% 2577

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Victory Capital Management's CDLX Position: Q1 2022 in Review

Victory Capital Management sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 455 shares — an estimated $301K sold.

Victory Capital Management first reported a position in CDLX in Q3 2019 and held it in 10 quarters. The position peaked at $22.1M in Q2 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

  • Victory Capital Management reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 455 Cardlytics shares in Q1 2022, an estimated $301K.
  • Victory Capital Management first reported a position in Cardlytics in Q3 2019 and held it in 10 quarters.
  • Victory Capital Management's Cardlytics position peaked at $22.1M in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.